Inovio Pharma (INO) Swings to Q3 Profit

Inovio Pharma (NASDAQ: INO) reported Q3 EPS of $0.07, versus ($0.12) reported last year. Revenue for the quarter came in at $24.18 million, versus $1.84 million reported last year.

For earnings history and earnings-related data on Inovio Pharma (INO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79